Ticker ALRN – Aileron Therapeutics – sales, description, marketcap – Tickerday.com

ALRN

Aileron Therapeutics

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 47.90M; Volume: 117.06K; AvgVol 3m: 789.75K; Beta: ;

Cost estimate:

P/E: ; EPS: -0.92; EPS growth quarter/prev quarter: 46.00%;

EPS growth this year: 44.10%; EPS growth past 5 years: -1.80%;

EPS ttm: -0.92;

P/S: ; P/B: 2.32; P/Cashflow: 2.73; P/FCF: ;

Sales: ; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -97.70%; ROE – return on equity: -160.00%; LT Debt/Equity: 0.01; Total Debt/Equity: 0.02;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 1.10%; Insider Transactions:;

Institutional Ownership: 17.60%; Institutional Transactions: 38.35%;

Data update: 07.10.2020.

Leave a comment

Your email address will not be published. Required fields are marked *